Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Facilities Descriptions for Grants

Navigate to specific facility descriptions by clicking on links below. An MS Word version of this list can be downloaded for easy pasting into grant documents.





Biochemistry Stores

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

Biochemistry Stores is a part of the Biochemistry Department of the Carver College of Medicine at the University of Iowa. As a research supply storeroom that purchases and dispenses nearly $3 million per year in inventory, the Biochemistry Stores services: all University of Iowa research laboratory units, units of the University of Iowa Hospitals and Clinics, University of Iowa students, Veterans Affairs Medical Center, and any other facilities having funding through the University of Iowa. Biochemistry Stores stocks a broad range of research chemicals, labware, glassware, expendables, and other necessary research supplies, and uses high sales volume to negotiate the purchase of the highest quality inventory at the lowest possible prices. Products are dispensed on a walk-in basis in a quick and efficient manner.


Bioengineering Services

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

Bioengineering Services provides professional maintenance of The University of Iowa Hospitals and Clinics' patient-care and the Carver College of Medicine's research equipment. Scheduled preventative maintenance, repair and pre-construction and general technical consultation services are available.


Biomedical Informatics Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The University of Iowa Institute for Clinical and Translational Science’s Biomedical Informatics Core (BMI) helps in the capture, management and analysis of human subjects data. BMI maintains a clinical research data warehouse that contains data from electronic medical records linked to a growing number of external data including bio-sample data, genomic data, and cancer registries. Investigators are able to use tools such as TriNetX to explore this data.  BMI also provides access to REDCap for collaborative and compliant data capture and management and to UI BioSHARE to manage information about bio-samples. BMI supports multi-instituional medical record data queries via PCORnet and TriNetX.  BMI also has a team of developers to assist with custom application development, especially for mobile device applications and to explore new techniques such as Natural Language Processing (NLP).


Biological Safety Level III Laboratories

The Carver College of Medicine's Biological Safety Level III (BSL3) Laboratory facility provides researchers with state-of-the-art laboratories in which to safely study BSL3 select and non-select agents and toxins regulated by both the Centers for Disease Control and Prevention and the U.S. Department of Agriculture.  The facility has been designed to safely accommodate research, clinical, and diagnostic procedures, including animal housing areas for rodents and other small animals.  In addition to the animal areas, there are additional individual laboraties to accommodate work for tissue culture, virology, microbiology, and molecular biology.  The facility allows up to approximately 10 researchers to work simultaneously.

The BSL3 facility houses a Zeiss Axiovert 200M inverted fluorescence microscope complete with an environmental chamber, allowing researchers to visualize microbe-host cell interactions and responses in real time.  This powerful system provides our researchers with the unparalleled ability to perform a range of microscopy experiments that otherwise would not be possible as all BSL3 III samples must be inactivated prior to removal from the laboratory. 


Biomedical Research Store

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Biomedical Research Store provides University of Iowa research investigators easy procurement of common molecular and cell biology enzymes, reagents and kits.  Large volume contracts enable the store to negotiate very low prices as well as eliminate all shipping and packaging fees.


Biostatistics Consulting Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Biostatistics Consulting Center is a unit within the Biostatistics Department of the College of Public Health. The Consulting Center experts provide statistical consulting for the CCOM researchers, as well as other health science researchers at the University of Iowa Colleges of Dentistry, Nursing, Pharmacy, and Liberal Arts and Sciences. The Consulting Center assists researchers with all phases of basic science, clinical, and epidemiologic research. Specifically, the Consulting Center can assist with grant proposal development, assist with study design, develop efficient data management strategies, perform appropriate statistical analysis, and assist in writing reports for scientific publication.


Center for Biocatalysis and Bioprocessing

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Center for Biocatalysis and Bioprocessing (CBB) is an interdisciplinary research center dedicated to the advancement of biocatalytic sciences. The center operates a core Microbial Fermentation and Bioprocessing Facility that provides expertise in both upstream and downstream bioprocesses to: a) optimize production of highly-valued biomolecules, b) scale-up these processes, and c) perform pilot-scale manufacturing of products at the highest level of quality control. Examples of targeted products include vaccines, enzymes, binding proteins, growth hormones, DNA, RNA, and bio-transformation products. Conventional academic biomanufacturing is performed in our Research and Process Development (RPD) suite. A distinguishing feature of the CBB core facility is the operation of a second suite that focuses on production under current good manufacturing practices (cGMP) conditions. This GMP suite offers the preparation of high quality biotechnology products produced under regulations mandated by the 2008 FDA guidance for quality manufacturing of compounds designed for Phase 1 clinical trials. The information provided by the GMP manufacturing of putative therapeutics is suitable for Investigational New Drug (IND) applications. Fermentations can be scaled up from shake flasks to 1000 L volumes within our RPD suite and up to 300 L volumes in our GMP suite. All biomanufacturing processes are performed by professional staff trained in laboratory practices and quality control.  


Central Microscopy Research Facilities

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Central Microscopy Research Facilities (CMRF) offers a wide variety of research services, educational/training opportunities, and instrumentation within two campus locations. The main laboratory, located in Eckstein Medical Research Building within the College of Medicine, emphasizes imaging of biological samples by offering epi- and confocal fluorescence microscopy as well as scanning, transmission, and freeze fracture electron microscopy. CMRF instrumentation includes a STED super-resolution microscope, a TIRF microscope, an epifluorescence microscope with motorized X-Y-Z stage and environmental chamber for multi-RO1 time-lapse microscopy. The CMRF has a complete repertoire of instruments and services for electron microscopy including specialized staining and embedding techniques, negative staining, metal coating, and cryo-fixation for analysis with a JEOL JEM 1230 for TEM and Hitachi S-3400N for SEM.  A Hitachi S-4800 FESEM is available for high-resolution imaging of sample surfaces. The CMRF also provides all the instruments and materials for routine histological processing, staining, and visualization for both frozen and aldehyde-fixed tissue.  In addition, the CMRF maintains licenses and expertise in data analysis with the Bitplane Imaris software and Fiji/ImageJ open-source package. The CMRF supports both the experienced and novice investigator and provides training for independent use of resources. Alternatively, all or parts of a project can be handled by the staff. Major instrumentation within the CMRF is available 24 hours a day and 7 days a week.


Comparative Pathology Laboratory

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Comparative Pathology Laboratory (CPL) works closely with investigators to provide full service pathology, tissue handling, and histology services in order to maximize the impact, relevance and quality of research studies modeling human disease. The CPL is headed by veterinary pathologists, Dr. Katherine N. Gibson-Corley and Dr. David K. Meyerholz, who are trained in comparative pathology and can also provide a variety of consulting services. The facility provides all levels of tissue processing, including necropsy, routine histology, and a large panel of immunohistochemistry markers.  The facility has four certified histotechnologists, and two research associates with vast experience in pathology techniques. Additionally, the CPL has the medical resources of over 30 physician pathologists specialized in a wide-range of tissue pathologies.


Developmental Studies Hybridoma Bank

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Developmental Studies Hybridoma Bank (DSHB) is a national resource created by the NIH in 1985 and housed at the University of Iowa. The DSHB stores and distributes hybridomas and the monoclonal antibodies (MAbs) they produce at cost to the general scientific community in order to facilitate scientific research. Our priorities are to 1) allow researchers to test multiple MAbs without commitment of significant funds, and continue to utilize those of interest without worry of expense; 2) relieve scientists of the time and expense of distributing hybridomas and MAbs they develop; 3) assure the scientific community that MAbs with limited demand remain available. The DSHB has over 5,000 hybridomas obtained from a variety of individuals and institutions, including the NIH Protein Capture Reagent Program, the National Cancer Institute, the European Molecular Biology Laboratory and the Muscular Dystrophy Association, and distributes over 65,000 samples per year to investigators around the world.


Electron Spin Resonance Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Electron Spin Resonance Facility provides expertise and instrumentation to pursue research questions dealing with oxygen free radicals, singlet oxygen, nitric oxide, and the array of related oxidants and antioxidants that influence the overall redox environment of cells, tissues, and whole organisms.  The facility houses two Bruker EMX ESR Spectrometers and a Varian E-4 ESR.


Flow Cytometry Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The 1,200-square foot Flow Cytometry Facility is located in the Eckstein Medical Research Building (EMRB). The facility has one magnetic-based and eight laser-based instruments whose major purpose is the identification and isolation of cell populations. The two cell sorters are the Becton Dickinson Aria II and the Becton Dickinson FACS Aria Fusion that both operate in a biological safety hood allowing sorting of live human cells and cells exposed to infectious agents. The facility also has three Becton Dickinson LSR II instruments for multi-color flow cytometry analysis, a Becton Dickinson FACSCalibur, a BioRad Bioplex (Luminex 200s), a Miltenyi autoMACS and a Cytek Aurora. The cell sorters are operated by dedicated technicians M-F, 8am-6pm and other instruments are available 24/7 upon suitable training. The facility provides scientific and technical personnel who are available for consultation in designing experimental protocols and training in the use of bench-top instruments and software programs for the interpretation and analysis of data. Cell preparation protocols are available on the facility’s website and publication quality output is available upon request. Offline data analysis using SpectroFloTM, FlowJoTM, DiVaTM, and ModFITTM is accomplished through the facility's system of networked computers equipped with correspondingly maintained licenses. Data are also accessible remotely through the facility's dedicated file servers, which provide data storage for at least ten years.


Genome Editing Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Genome Editing Facility provides centralized instrumentation and expertise for the generation, breeding and analysis of both transgenic and gene-targeted mice. The facility is comprised of four personnel trained in a variety of mouse embryo manipulations for producing genome-engineered mice. This includes transgenesis and CRISPR/Cas9 HDR approaches using pronuclear microinjection.  Additional services include the design and validation of transgenic constructs and CRISPR/Cas9 reagents, screening of founder animals, mouse colony genotyping, and backcrossing strains. The facility also provides services and storage for embryo and sperm cryopreservation, as well embryo and mouse re-derivation and in vitro fertilization of cryopreserved sperm. The facility performs mouse embryonic stem cell evaluation, expansion and injection into blastocysts.  The facility maintains all animals in strict specific pathogen free (SPF) barrier conditions and has three wet laboratories, a microscopy suite, a tissue culture room, and a molecular biology laboratory. The facility currently has a 100% founder success rate with nearly 300 different constructs.


High Performance Computing (Research Services)

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Information Technology Services’ Research Services department provides high-performance computing (HPC) resources, storage, scientific software, and support for members of the campus community, including:

  • Argon, a locally-hosted HPC resource, which is managed by specialists who provide support and consultation services on data stewardship, compliance, scientific software, and more. It features approximately 15,000 processor cores and 110 GPU accelerators (both Infiniband and Omnipath interconnects).
  • Several RS consultants serve as U.S. National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE ) Campus Champions. The XSEDE portfolio of federated, advanced computational resources and services is more diverse and powerful than a single institution could afford, on its own. It is funded by the U.S. taxpayer investment, and is available at no cost to U.S. researchers and their collaborators.
  • The Interactive Data Analytics Service (IDAS) is a high performance computing resource that supports large-scale and collaborative data analytics workflows involving RStudio for R, Jupyter Notebook for, but not limited to Python, and Remote Desktop. Users may access HPC resources within the IDAS interface, while performing interactive data analysis tasks with applications used for machine learning and other artificial intelligence workflows.
  • Two locally-hosted storage services are available: the Research Data Storage Service (RDSS), and Large Data Storage Service (LSS). The first 5 TB on either are available at no cost to researchers who have a faculty appointment and their labs. Additional 1 TB increments are available upon request for a fee.

Iowa’s research computing resources are attached to the local network by 10 GB Ethernet connections, and beyond, with 100 GB connections to Internet2. Iowa’s relationship with I2 facilitates trusted (InCommon & eduGAIN via GÉANT) collaborations among researchers at 317 institutions of higher education, 59 leading corporations, 60 affiliate and federal affiliate members, 43 regional and state education networks, and more than 70 national research and education network partners in more than 100 countries.  


High Resolution Mass Spectrometry Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The High Resolution Mass Spectrometry Facility (HRMSF) provides information pertaining to the molecular weight, elemental composition, and molecular structure of chemical compounds, which allows the identification and quantitative analysis of components of complex mixtures. The HRMSF can also perform tandem mass spectrometry (MS-MS) experiments, which are used to assist in structure determination of unknown molecules. 

The HRMSF has four open-access instruments, one GC/MS and three LC/MS that are available to on-campus researchers who have been trained by the HRMSF staff.  Instruments include:

1) A Waters GCT Premier GC mass spectrometer used with either electron ionization (EI) or chemical ionization (CI). 2) A Waters Q-TOF Premier high-resolution hybrid quadrupole time-of-flight mass spectrometer configured with electrospray ionization (ESI) capabilities. This is interfaced with a Waters Acquity ultra-high-pressure liquid chromatography system (UPLC) and an autosampler that holds two plates each with 48 vial positions or two 96-well plates. The Q-TOF premier is used for accurate mass massuerments and is also capable of performing tandem mass spectrometry (MS/MS) experiments.  3) A second Q-TOF Premier is configured for direct infusion analysis. 4) A Waters Acquity triple quadrupole mass spectrometer with an Acquity H Class UPLC used for quantitative analysis of complex mixtures using multiple reactions monitoring (MRM) scanning techniques.


High Throughput Screening Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The University of Iowa High Throughput Screening Facility (UIHTS) provides a high-throughput platform that integrates robotics, detection systems, and chemical/biologic libraries to enable highly flexible screening services, project management, grant assistance, and assay/technology development for investigators at the University of Iowa. Instrumentation systems allow for scalable screening approaches for drug discovery and development through screening of large chemical/biologic libraries and also facilitate molecular probe discovery for mechanism of action studies of chemical biology by screening focused and intellectually-designed compound collections.

The UIHTS is equipped to perform high-throughput screening in 96, 384, and 1536-well formats with plate reader detection (Perkin-Elmer EnVision) using absorbance, fluorescence, and luminescence, including advanced FRET and BRET techniques. UIHTS is also equipped to perform high-content screening (HCS, Perkin Elmer Operetta Confocal Imaging System) to detect and quantify phenotypic changes, i.e., cell differentiation, cell migration, neurite outgrowth, and target trafficking; or by fluorescence intensities for target protein expression, transcription factor, or signaling pathway analysis. HTS and HCS systems are integrated with robotics for plate handling and assay execution, suitable for small- or large-scale compound library screens that are fully automated.

UIHTS holds both small molecule drug libraries and biological libraries. Current small molecule libraries include: 1) an FDA-approved drug library containing 1,018 compounds that are all FDA approved. This library is primarily used to identify drugs that can be repurposed. 2) A pathway or target selective collection (PTSC) containing 1,310 compounds for mechanism interrogation. 3) The Spectrum Library from MicroSource (MSSP) containing 2,320 structurally diverse compounds including marketed and experimental drugs as well as natural products. This library is typically the starting point of pilot screenings. 4) ChemBridge, the Diverset, a collection of 50,000 small molecules representing a wide swath of chemical space, optimized to be “drug like,” considering factors such as partition coefficient and Lipinski-like rules. 5) Maybridge Ro3 Diversity Fragment Library containing 1,000 carefully selected fragments for the optimal balance between broad coverage of lead-like diversity space and the number of fragments. 6) NIH NCI NExT collection of 83,536 small molecules, which is a general screening set that was designed to identify lead compounds for drug discovery projects. It is comprised of three non-separable subsets of the Legacy molecular library small molecule repository (MLSMR), 15 privileged scaffolds in two Diversity subsets. Biological libraries cover the cell collections of melanoma cell lines and breast cancer cell lines, and arrayed Kinome-wide CRISPR gRNA library from Integrated DNA Technologies.


Hybridoma Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

This facility is available for use by Carver College of Medicine investigators through a partnership with the Iowa State University Office of Biotechnology in Ames, Iowa.

The Hybridoma Facility of the Iowa State University Office of Biotechnology provides complete resources for raising monoclonal or polyclonal antibodies.  Techniques are provided on an individual charge basis and include animal immunization, cell fusion and hybridoma culture maintenance, cell culture and maintenance of other cell lines used in biotechnology and virology labs, large-scale mammalian cell culture (bioreactor), blood sera collection, antibody purification and isotyping, cryopreservation and cryostorage of cell lines (-140o C), and ELISA tests. 


Iowa Institute of Human Genetics: Bioinformatics Division

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Bioinformatics Division of the Iowa Institute of Human Genetics (IIHG) provides the expertise and computational resources to analyze complex DNA and RNA sequencing datasets. Routine analysis includes evaluation of large-scale sequencing experiments, such as variant calling from research and clinical exomes or targeted panels, quantitation and statistical evaluation of data from *-seq experiments (e.g., RNA-Seq, ChIP-Seq, ATAC-seq, Methy-DIP-seq, etc…), as well as single-cell transcriptomics from the 10x Genomics system. Staff members have diverse training in biological data analysis, and are available to work with investigators on short-term projects, grant applications, and longer-term research collaborations. The Bioinformatics group has preferred access to 560 slots of on-campus, high-performance computing with high-bandwidth dedicated storage attached to the clusters. They maintain a private, CAP- and HIPAA-compliant clinical Galaxy installation for the evaluation of clinical NGS data for the IIHG’s popular “KidneySeq” test. The group also maintains a public-facing Galaxy installation for University of Iowa researchers and licenses for analysis software including Ingenuity Pathway Analysis, iPathwayGuide, and Partek Genomic Suite. The Bioinformatics group provides educational services for researchers looking to process and analyze their data with new computational techniques. These include workshops that offer hands-on tutorial sessions that focus on different topics such as the UCSC Genome Browser, Kallisto/Sleuth and R-programming language, and building a web presence on Twitter and YouTube, as well as sponsored seminars featuring outside speakers in computational biology.


Iowa Institute of Human Genetics: Genomics Division

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Genomics Division of the Iowa Institute of Human Genetics provides a broad spectrum of technologies and resources to support nucleic acid- and genomics-based initiatives to the research and clinical communities. The Genomics Division also provides educational support in the form of scientific seminars and mini-syposiums focused on genomics-based technologies and resources. The technologies provided by the Genomics Division include:

  • Genome Sequencing: Next-generation sequence data are provided with a NovaSeq 6000 that features dual-flow cells (delivering the highest throughput and lowest price-per-sample across multiple applications) and a MiSeq benchtop sequencer that permits low throughput genome sequencing. These sequencing platforms are complemented by a Covaris E220 96-well plate sonicator, SciClone and EpMotion liquid handling robots that facilitate high-throughput sample preparation, and two 10X Genomics Chromium drop-seq-based technology systems used for single-cell sequencing applications.
  • DNA Sequencing: Sanger-based DNA sequencing is provided with Applied Biosystems Models 3730 (48-capillary) and 3730xl (96-capillary) DNA sequencers. Sequence data are accessed by investigators via a custom online web system. 
  • DNA Microarray: Array-based genotyping and methylation profiling are provided with the Illumina iScan BeadArray system.
  • Nucleic Acid quality assessment:  DNA and RNA quality and quantity can be assessed using a variety of systems including a Bioanalyzer, Fragment Analyzer, Qubit fluorometers, and Trinean and Nanodrop spectrophotometers.
  • Real-time quantitative and digital PCR: For real-time PCR analysis, the facility has an ABI QuantiStudio Flex 7 and two ABI Model 7900 instruments, all configured to support array card, 96- and 384-well formats. For high-throughput genotyping, the facility provides Fluidigm EP1 and BioMark systems with controllers to run the 48x48, 96x96, and 192x24 (target x sample) BioMark Dynamic arrays. Digital PCR is provided with a BioRad QX200 droplet digital PCR system, enabling ultrasensitive and absolute quantification of nucleic acid targets. The system uses the same hydrolysis probe (Taqman)- or EvaGreen (SYBR-like)-based assays and provides the ability to quantify template molecules that may be undetectable using the traditional real-time PCR techniques. 


Magnetic Resonance Research Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Magnetic Resonance Research Facility (MRRF) at the University of Iowa is dedicated to providing MR imaging equipment and expertise to any researcher. Two field strengths are available (1.5T, 3T, and 7T). Oversight is provided by both internal and external research advisory committees. The internal research committee reviews new project proposals and equipment acquisitions. The MRRF currently supports more than 60 research imaging projects from fourteen different departments representing five colleges within the University of Iowa

The MRRF currently has two research-dedicated whole-body MR scanners (3.0T GE Discovery, 7.0T GE MR950) for human and large-animal imaging, and one small-animal MR scanner (7.0T GE 901 Discovery) available for research purposes. The whole body scanners are fully outfitted for fMRI imaging, including stimulus presentation software (E-Prime, Presentation, Matlab), auditory and visual stimulus hardware (Avotec), and physiological monitoring (Biopac). A shared clinical/research 3T scanner (3T Siemens Skyra ) is available in the clinical imaging suite. Additionally, an MRI Simulator is available to all researchers.

The MRRF utilizes the XNAT system for data archiving and for distribution of images to the various research projects. In addition, the facility is outfitted with a number of image analysis tools, including FSL, AFNI, Slicer3, ImageJ and BRAINS. The facility also has the ability to develop custom MR pulse sequences and reconstructions using the GE Epic and orchestra tools, respectively.


Metabolic Phenotyping Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Metabolic Phenotyping Core provides investigators specialized and non-invasive metabolic assays that are essential in phenotyping mouse and other animal models with diabetes, its complications, obesity, and related metabolic disorders.

The central services of the core include: 

  • Determining whole animal energy expenditure using Metabolic Chambers: Promethion (Sable Systems International) and CLAMS (Comprehensive Lab Animal Monitoring System, Columbus Instruments). This is a non-invasive measurement of food intake, energy expenditure, respiratory exchange ratio and physical activity.
  • Measuring whole body composition with a Bruker MiniSpec in mice and rats.
  • Hyperinsulinemic-euglycemic clamp experiments to assess in vivo insulin action, insulin signaling, and glucose metabolism in awake mice.
  • Hyperglycemic clamp experiments to assess in vivo pancreatic beta-cell function (i.e., glucose-induced insulin secretion) and the effect of hyperglycemia on glucose metabolism (i.e., glucose toxicity).
  • Mitochondrial bioenergetics: tissue/cellular/isolated mitochondria oxygen consumption using the XF-24 Extracellular Flux Analyzer; mitochondrial respirometry for tissue (permeabilized mouse heart and soleus) and isolated mitochondria with the O2K from OROBOROS.
  • Glucose and insulin tolerance tests.

Specific equipment available at the Metabolic Phenotyping Core includes: a Seahorse XF-24 analyzer, two O2K from OROBOROS, two Bruker Minispecs, and Metabolic Chambers.


Metabolomics Core Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Metabolomics Core Facility provides investigators with metabolite profiling and isotope tracer analyses using high-resolution mass spectrometry interfaced with either gas chromatography (GC) or liquid chromatography (LC). The semi-targeted high resolution GC-MS protocol identifies and measures over 100 metabolites. These include TCA cycle and glycolytic/gluconeogenic intermediates as well as amino acids, sugars, neurotransmitters, and fatty acids. The high-resolution LC-MS analysis focuses on compounds that are not amendable to the high temperatures of gas chromatography such as AMP, ADP, ATP and other redox metabolites, coenzymes, nucleotides, and complex lipids. 

The Metabolomics Core Facility currently has three mass spectrometers. The first is a Thermo Q Exactive GC (QE-GC), which is a high resolution/mass accuracy, hybrid quadrupole-Orbitrap mass spectrometer (R=120,000).  The second is an ISQ LT GC-MS, which is a low resolution single quadrupole mass spectrometer.  Each GC-MS is interfaced with a Trace 1310 gas chromatograph and autosampler. Both GC-MS instruments have electron ionization (EI) and chemical ionization (CI) capabilities utilized for metabolite profiling and isotope tracer studies, respectively. The third instrument is a high resolution LC-MS system, a Thermo Q Exactive LC.  It is a hybrid quadrupole-Orbitrap mass spectrometer (R=140,000) interfaced with a Vanquish UHPLC system.  The Vanquish is a ultra-high pressure liquid chromatograph (UHPLC), which includes a binary solvent pump, column heater, and autosampler. The QE-LC is capable of performing tandem mass spectrometry (MS/MS) experiments, which provides options for qualitative and quantitative applications.


Neural Circuits and Behavior Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Neural Circuits and Behavior Core (NCBC) provides equipment, facilities, and services to aid investigators in performing behavioral assays of motor and sensory function, learning and memory, anxiety-like behaviors, social interaction, and sleep. The NCBC also provides imaging equipment and services for investigating the neural substrates of these behaviors, including a LaVision UltraMicroscope II lightsheet microscope for fast volumetric imaging of brains, two Bruker multiphoton microscopes, a Neurophotometrics fiber photometry system, and Bitplane Imaris software for displaying and analyzing 3D-reconstructed volumes.


Nuclear Magnetic Resonance Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Carver College of Medicine Nuclear Magnetic Resonance Facility supports the biomedical research community with three instruments, a wide variety of techniques, and the expertise to probe structure and dynamics of a wide range of biomolecules. A full spectroscopic and interpretive service is offered, as well as assistance and training for researchers who wish to perform their own experiments.  Instrumentation includes: a Bruker Avance II 800 MHz equipped with a TCI cryoprobe and 60 sample changer with barcode reader, a Bruker Avance NEO 600 MHz with a QCI-P cryoprobe, and a Bruker Avance II 500 MHz with a TXI probe and 60 sample changer with barcode reader.


Office of Animal Resources

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Office of Animal Resources (OAR) provides the expertise, care, and resources necessary for the maintenance of research animals.  The OAR's mission is preservation of the university's animal research privilege and maintenance of a quality animal research environment. The animal research facilities are comprised of approximately 170,000 square feet of housing and support space and accommodate multiple species in multiple campus locations.  The OAR team includes five full-time veterinarians (all are board certified by the American College of Laboratory Animal Medicine, ACLAM), five veterinary technicians and 50+ animal care technicians.  This team of skilled animal care specialists can advise and instruct researchers on appropriate methods for anesthesia/analgesia, surgery, biosampling, and euthanasia.

The university's animal research program has a PHS Animal Welfare Assurance (A3021-01), is a registered research facility with the United States Department of Agriculture (USDA No. 42-R-0004), and is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC).  The Institutional Animal Care and Use Committee (IACUC) reviews all research and teaching protocols involving the use of animals and fulfills all other mandated oversight and compliance responsibilities. 


The Institutional Animal Care and Use Committee (IACUC)

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

Note: information should be in the “Vertebrate Animals” attachment, not “Facilities & Other Resources” attachment. A Vertebrate Animals attachment should be included if you answered “Yes” to the question “Are Vertebrate Animals Used?” on the R.220 – R&R Other Project Information Form. Information should include the following:

  1. Description of Procedures (Vertebrate Animals Section)

Provide a concise description of the proposed procedures to be used that involve live vertebrate animals in the work outlined in the Research Strategy section. Identify the species, strains, ages, sex, and total number of animals by species to be used in the proposed work. If dogs or cats are proposed, provide the source of the animals.

  1. Justifications (Vertebrate Animal Section)

Provide justification that the species are appropriate for the proposed research. Explain why the research goals cannot be accomplished using an alternative model (e.g., computational, human, invertebrate, in vitro).

  1. Minimization of Pain and Distress (Vertebrate Animal Section)

Describe the interventions including analgesia, anesthesia, sedation, palliative care, and humane endpoints to minimize discomfort, distress, pain, and injury.

  1. Method of Euthanasia (Cover Page Supplement / PHS Fellowship Supplemental Form)

Provide a justification for methods of euthanasia that are not consistent with the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals.

Recommended text from UI IACUC: Animals will be euthanized by methods consistent with the recommendations of the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals: 2013 Edition.
Note:  If you need assistance to determine whether or not your method of euthanasia is consistent with the 2013 AVMA Euthanasia Guidelines, please contact the IACUC Office at 319-335-7985, or iacuc@uiowa.edu(link sends e-mail).


Protein and Crystallography Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Protein and Crystallography Facility provides all necessary support and infrastructure to initiate and complete protein purification, biophysical characterization and structural studies. This includes three BioRad DuoFlow FPLCs for protein purification, a Wyatt NanoStar dynamic and static light scattering instrument for aggregation and protein size determination, a ForteBio Octet RED96 biolayer interferometry system for protein:protein and protein:DNA binding studies, a thermal shift assay workflow to identify protein stabilization conditions using a BioRad CFX96 qPCR instrument, a TTP LabTech Mosquito nano-volume robot for arraying multiple crystallization conditions, a Formulatrix RockImager2 for imaging crystal trays, and a TTP LabTech Dragonfly liquid-handling robot for preparation of custom solution arrays. Diffraction data can be collected locally using two R-AXIS IV++ systems mounted on rotating anode generators or by shipping to our 4.2.2 Molecular Biology Consortium beam line at the Advanced Light Source (Lawrence Berkeley National Laboratory) where data collection is performed remotely from Iowa. The facility also enables analysis by small-angle X-ray scattering (SAXS) in line with size exclusion chromatography (SEC) and multi-angle light scattering (MALS) whereby data are routinely collected in-person at the 18-ID-D Bio-CAT beam line at the Advanced Photon Source (Argonne National Laboratory) or at the 12.3.1 SIBYLS beam line at ALS using their mail-in system. The facility is also set up with several workstations and an SBGrid Consortium membership, which provides updated versions of all necessary structural biology and molecular modeling software.


Protein Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

This facility is available for use by Carver College of Medicine investigators through a partnership with the Iowa State University Office of Biotechnology in Ames, Iowa.

The Protein Facility of the Iowa State University Office of Biotechnology is open to faculty and students from the university, other educational institutions, and industry scientists. The facility offers protein/peptide sequencing, large- and small-scale peptide synthesis (Fmoc), matrix-assisted laser desorption/ionization (MALDI) mass spectrometry, SDS-PAGE/electroblotting, 2-D gel electrophoresis, isoelectric focusing (IEF), in-gel and solution digestion, tandem mass spectrometry (LC-MS/MS), ion mobility mass spectrometry (IM-MS), digital image acquisition and analysis using the Typhoon imaging system and the 2D gel documentation/analysis system, and semi-preparative, analytical and micro-analytical high performance liquid chromatography (HPLC). 


Proteomics Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Proteomics Facility houses mass-spectrometers and supporting instrumentation for analysis of proteins and peptides. Services include protein identification, protein expression profiling, accurate weight determination for intact macromolecules and conjugates, characterization of post-translational modifications, and rapid biotyping to determine bacterial strains. Data analysis is provided using MASCOT, SEQUEST and SpectrumMill data analyses with final reporting in Scaffold or Excel format. Instrumentation includes a Bruker Autoflex III MALDI TOF/TOF, Thermo LUMOS Orbitrap, and a Thermo Q-Exactive Orbitrap.


Radiation and Free Radical Research Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

RFRRC Core Director: Douglas R. Spitz, PhD (Oxidative Stress and Thiol Biochemistry); RFRRC Core Co-Directors: Frederick E. Domann, PhD (Molecular Biology), Prabhat C. Goswami, PhD (Radiation Biology and Cell Cycle), and Garry R. Buettner, PhD (EPR Spectroscopy and Physical Chemistry).

The Radiation and Free Radical Research Core (RFRRC) was established to provide free radical and radiation biology expertise, reagents, technologies, and analysis for investigators doing basic, pre-clinical, and clinical research. The three basic services provided by the core are: 1) Ionizing radiation services and phosphorimaging; 2) Electron paramagnetic resonance spectroscopy to measure oxygen free radicals, singlet oxygen, nitric oxide and the array of related oxidants; and 3) Antioxidant enzyme services to modify and measure molecules responsible for free radical formation and oxidative damage in cells such as anti-oxidant proteins and small molecular weight cellular thiols.

1) IRS – Ionizing Radiation Services:

Ionizing Radiation Services are available under the supervision of Co-Director (Dr Goswami) or Amanda Kalen, the research assistant responsible for the radiation unit. The Radiation Facility is located in B164 Medical Laboratories.  The radiation sources available include a 1 orthovoltage X-ray machine and an 8,148 Curies cesium-137 gamma ray source.  The x-ray unit is a microprocessor-controlled orthovoltage generator.  The unit is a Pantak Therapax DXT 300 (Pantak Inc., East Haven, CT) with maximum x-ray energy of 300 kVp.  The radiation facility housing the new x-ray generator was extensively renovated to contain the new unit and now has the flexibility to accommodate almost any irradiation orientation and device required by the user.  The unit may be adapted for the irradiation of cells in tubes or in culture, as well as of animals in customized devices. The gamma ray source is capable of delivering low or high dose rates of monoenergetic (0.667 MeV) gamma radiation, the range being from 40-3200 cGy/minute.  The x-ray and gamma-ray facilities have been used for total body or partial body irradiation of tumors in experimental mice, rats, dogs, as well as cancer or normal cell cultures grown in vitro. 

2) EPR – Electron Paramagnetic Resonance Services:

The EPR Facility in the RFRRC supports the basic and clinical research efforts of members of the Holden Comprehensive Cancer Center by providing the tools and expertise to detect and quantify free radicals, small molecular weight dietary antioxidants and pro-oxidants. One of the most valuable services the Facility provides is consultative expertise in the study of free radicals, related oxidants and antioxidants.

The EPR facility assists users in the detection of: 

1.  Free radicals in systems that range from solids, solutions, cells, tissues and whole animals;

2.  Nitric oxide and related metabolites;

3.  MDA/TBARS, indicators of lipid peroxidation that are detected with our fluorescence spectrometer; 

4.  Fluorescent dyes, used as indicators of oxidation;

5.  UV-Vis spectroscopy: Our HP 8453 Diode Array UV-Vis spectrometer; 

6.  Oxygen concentration;

7.  Oxidative stress-indicators using HPLC: e.g. DNA damage, antioxidants such as vitamins C and E, beta-carotene, etc;

8.  Cell volume measurements;

9.  Seahorse Metabolic Profiling Services.

3) AES – Antioxidant Enzyme Services: 

The purpose of the Antioxidant Enzyme Services (AES) is to provide free radical biology expertise, reagents, technologies, and analysis for individual investigators doing basic, per-clinical, and clinical research. AES staff will carry out the proposed work or will advise the user and his staff on how to perform and analyze the experiments. Some of this work, particularly transfections of new cDNAs or new cell lines as well as the development of antisense reagents, will be developmental and distributed to investigators as they become available. The AES will aid in vector development and distribution, enzyme activity assays, thiol analysis, western, and quantitative RTPCR analysis. The following enzyme assays will be run: copper-and zinc-containing superoxide dismutase (CuZnSOD), thioredoxin reductase (TrxR), manganese-containing superoxide dismutase (MnSOD), catalase (CAT), glutathione transferases (GSTs), glutamyl transpeptidase (GGT), gamma-glutamylcysteine synthetase (GCS), and glutathione peroxidases (GPx, both cytosolic and phospholipid). Assays for the detection of pro-oxidant production (superoxide, hydrogen peroxide, lipid peroxidation products, etc.) will also be available. Antibodies, cDNA probes, adenoviral, and lentiviral vectors coding for primary antioxidant enzymes as well as stably and transiently transfected cells will be provided. The AES will also aid in transfecting cDNAs into cell lines of interest to investigators. The AES continues to develop and maintain novel reagents for studies in free radical biology including: antibodies, cDNAs, antisense reagents, and expression vectors for antioxidant proteins including thioredoxin, glutaredoxin, thioredoxin reductases, and thioredoxin peroxidases. This core will provide services to measure cellular redox couples including GSH/GSSG, oxidized and reduced thioredoxin, and NADP+/NADPH ratios as well an electron transport chain complex and TCA cycle activities.


Scientific Editing and Research Communication Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Scientific Editing and Research Communication Core helps researchers succeed with their funding efforts and scholarship by providing in-depth advice on how to maximize the clarity of scientific documents.  The core is staffed by PhD-level scientists who offer detailed editorial review of grants, manuscripts, and other writing projects based on extensive experience in both laboratory research and editing of scientific content. Multiple levels of feedback are offered, including:

  • Mechanics: proofing for grammar, typographical, and other errors
  • Style and clarity: suggestions toward improving text flow
  • Presentation: suggestions toward highlighting the significance of the research, and in the case of multi-author documents, achieving a single voice
  • Science: pre-review from the perspective of a non-specialist reviewer; on request, feedback on how well scoring criteria for grants are covered.

Authors receive an annotated copy of their submission and can request one-on-one meetings at any time to discuss writing strategies, clarify their meaning, or discuss potential problem spots. Core staff also participate in didactic teaching of scientific writing and help to organize grant planning forums for investigators. These forums allow investigators to outline their grant-in-progress to core staff, departmental faculty, and any other suitable experts, and they receive feedback from this group based on a draft of their Specific Aims page and their presentation.


Small Animal Imaging Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Small Animal Imaging Core (SAIC) is a core facility of the Iowa Institute for Biomedical Imaging (IIBI) housed in the Pappajohn Biomedical Discovery Building. The SAIC occupies 5,500 square feet of space, including 7 imaging suites, 8 support rooms, and is contiguous to the primary barrier housing facility on campus.  The purpose of the SAIC is to provide instrumentation and technical services for non-invasive anatomical and physiological imaging of small animals and other biological samples.

The core instrumentation includes:

  • Micro-PET (Siemens Inveon DPET)
  • Micro-CT (Siemens Inveon CT (10 µm resolution)
  • Micro-SPECT (Siemens Inveon SPECT)
  • Optical imaging (Carestream MSFX-pro, IVIS)
  • Fluorescent imaging (Carestream MSFX-pro)
  • 3D X-ray/CT Microscope (Zeiss Xradia 520 Versa, submicron resolution)
  • 7T Preclinical MRI (7.0T GE 901 Discovery MRI small animal scanner) separately administered through the Magnetic Resonance Research Facility core
  • High-resolution micro-ultrasound imaging (Visualsonics Vevo) - administered separately
  • Optical Coherence Tomography

The SAIC operates an image-processing laboratory including four high-end workstations with a suite of multi-modality software available for use, including PMOD, and Inveon Research Workspace.  The SAIC administers its own 12 TB archive system, mirrored to offsite research networked storage.


Tissue Procurement Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Tissue Procurement Core (TPC) collects, processes and stores well-characterized human biospecimens (normal or tumor tissue, blood, etc.) to researchers for a variety of indications under an existing IRB approved protocol. Fresh, frozen or FFPE specimens can be provided to investigators.  Stored biomaterials are suitable for molecular genetic, biochemical, immunohistochemical, cellular, and pathological studies. The TPC also processes blood to PBMCs and to DNA or RNA and prepares DNA from saliva.  Additionally, the TPC can assist in isolating, aliquoting, and storing liquid specimens such as CSF or plasma. 


University of Iowa Microfabrication Facility

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The University of Iowa Microfabrication Facility (UIMF) is an interdisciplinary central research facility that provides access to state-of-the-art equipment in the areas of micro- and nano-fabrication, metrology, and device characterization, and offers expertise and advanced training courses in the same related areas. The purpose of the UIMF is:

  • To provide shared experimental capabilities with advanced equipment, skilled personnel and effective training
  • To train and support graduate and undergraduate research in the applications of micro- and nano-fabrication
  • To promote and enable high-quality research using a suite of micro- and nano-fabrication tools
  • To advance fundamental and technical knowledge in the area of micro- and nano-fabrication technologies
  • To promote multidisciplinary research and training through the use of micro- and nano-fabrication tools.

Key research areas enabled by the facility include optics, nanotechnology, sensors, micro- and nano-electronics, plasmonics, photovoltaics, spintronics, and high-resolution spectroscopy.


UI Pharmaceuticals

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

University of Iowa Pharmaceuticals (UIP) provides contract pharmaceutical services including pharmaceutical development, manufacturing, and testing. UIP can support the manufacturing and testing of both clinical and commercial finished products. UIP is a Food and Drug Administration-registered pharmaceutical manufacturing facility, providing expert pharmaceutical development services to clients around the world. Contract pharmaceutical services include:

  • Preformulation studies
  • Formulation development (including lyophilization cycle development)
  • Clinical supply manufacturing and testing
  • Small scale commercial manufacturing and testing
  • Analytical method development and validation
  • Routine quality control analysis
  • Stability studies
  • Active pharmaceutical ingredient (API) and excipient release testing

UIP is able to handle controlled substances schedules I - V and most potent and/or cytotoxic substances. UIP is able to manufacture most dosage forms including sterile solutions and lyophilized powders; tablets; capsules; and non-sterile semisolids and liquids. It is the largest and longest running facility of its kind offering this breadth of service in the United States, and has been providing contract pharmaceutical services in compliance with current Good Manufacturing Practices (GMP) for almost 45 years.


Viral Vector Core

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Viral Vector Core (VVC) produces and distributes viral vectors for gene expression. The VVC provides all services required in the design and construction of a wide variety of custom viral vectors.  The core also maintains a large catalog of “off the shelf” vectors for expression of common markers (e.g., Cre, GFP) without the need of a material transfer agreement (MTA). The VVC works with Adenovirus, Adeno-associated virus, Helper-dependent Adenovirus, lenti-virus, Vaccinia virus, Baculovirus, and others.



Iowa Institute for Biomedical Imaging

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Iowa Institute of Biomedical Imaging (IIBMI) was formed in 2007 and reflects a strong institutional support to biomedical imagine and image analysis and its importance for translational medical research. The mission of the IIBI is to foster efficient and cooperative inter-disciplinary and cross-college research and discovery in biomedical imaging, and to improve training and education within the broader community at the University of Iowa. The Institute focuses on research and discovery in biomedical imaging at the University of Iowa under one umbrella, in a multi-disciplinary process, facilitating new external industry relationships, new grant opportunities, and new educational processes at both the undergraduate and post-graduate levels. It is composed of an interdisciplinary group of established researchers from the Colleges of Medicine, Engineering, Liberal Arts and Sciences, and Public Health and brings together researchers from all areas of medicine, including programs in cardiovascular, pulmonary, and neurological research as well as psychiatric imaging and image analysis, and radiation treatment planning.


Iowa Institute for Human Genetics

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Iowa Institute of Human Genetics (IIHG) is dedicated to promoting clinical care, research, and education focused on the medical and scientific significance of variation in the human genome. It collaborates with partners worldwide and is open to all faculty, trainees and staff at the University of Iowa, Iowa State University, and the University of Northern Iowa. The unique environment at the University of Iowa provides unprecedented opportunities to make progress in the discovery and translational phases of human genetics and in doing so to advance genetic research and to improve genetic-based clinical care.

The IIHG provides researchers with a state-of-the-art, high-throughoutput genetic analysis facility and supports research focused on human genetics and personalized medicine. The expertise and resources available through the IIHG enable the coordination of large-scale gene discovery with targeted gene-based and disease-based clinical diagnostics to improve disease-specific treatment.

The IIHG also develops state-of-the-art diagnostic platforms that use targeted-sequence capture and massively parallel sequencing to interrogate large panels of genes implicated in a variety of genetic diseases. This initiative, undertaken in partnership with outstanding UIHC clinicians, facilitates genome-phenome integration and cutting edge personalized genomic medicine. Patients seen from throughout the USA as part of this initiative are also offered expertise in genetic counseling as a step towards translating genetic findings into improved healthcare.

The IIHG links research and clinical missions through education for the scientific community. Opportunities include an annual bioinformatics short course, a summer internship program for genetic counselling and bioinformatics, sponsoring various lectures, guest speakers and scientific workshops, and an annual precision medicine conference. In addition, the IIHG hosts mini-medical school lectures and career days in human genetics, and provides online brochures and educational materials to inform the community and patients and their families about genetics testing and genetic diseases.


Iowa Neuroscience Institute

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Iowa Neuroscience Institute (INI) is a comprehensive and cross-disciplinary neuroscience center within the Carver College of Medicine. Led by Ted Abel, PhD, the INI conducts research to find the causes of — and preventions, treatments, and cures for — the many diseases that affect the brain and nervous system. This involves integrating and supporting neuroscience research on the University of Iowa campus in order to provide a framework that will encourage research collaborations among INI faculty and with colleagues at other institutions, and to convey the excitement of neuroscience research to the public, both within the State of Iowa and nationally. As such, the INI provides a mechanism for establishing collaborative opportunities for the existing neuroscience community, and is home to a substantial number of new faculty members with diverse neuroscience research interests. The INI houses world-class scientists and provides synergy within the broader neuroscience community that leads to transformative research and an intellectually stimulating environment that supports innovation in basic science, opportunities for translational application, and the ability to investigate how the nervous system mediates behavior and how this goes awry in neurodevelopmental, psychiatric, and neurological disorders. The INI sponsors multiple annual events, including both intensive workshops and seminars for researchers and visiting scientists of international renown, as well as public outreach events including artists, writers, and intellectuals whose work touches on how neuroscience can inform and improve the human condition. INI faculty also reach out to state and local legislators, educators, and community leaders to advocate for the importance of neuroscience research for the promotion of human health and the well-being of our communities. 


University of Iowa Institute for Vision Research

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Institute for Vision Research leverages interdisciplinary research across four colleges and eight departments at the University of Iowa and is committed to finding answers that will help patients suffering from blinding eye diseases. As part of the Institute for Vision Research, the UI’s clinical stem cell transplantation program aims to restore useful vision to people with advanced stages of retinal degenerations—ranging from common conditions such as age-related macular degeneration to rare genetic forms of retinitis pigmentosa. The program seeks to use stem cells derived from the patient’s tissue, correct gene mutations, and transplant them into the patient’s retina to restore vision.


University of Iowa Institute for Clinical and Translational Science

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Institute for Clinical and Translational Science (ICTS) at the University of Iowa was established by the Iowa Board of Regents in 2007 with the mission to prioritize team-based research that engages the community using both technology and personal interactions to advance the delivery of health care and personal health and wellness. The ICTS is the home for clinical and translational science at the University of Iowa and leverages infrastructure that includes a 20,000 square foot Clinical Research Unit (CRU) that offers the physical space and experienced interdisciplinary support staff required to conduct and complete clinical research. The ICTS partners with all 11 colleges on campus and has a special emphasis on working in community partnerships between the academic medical center, local health care providers and the rural patient population. Iowa’s population demographics present an opportunity to engage rural communities as active research participants in the biomedical enterprise. Specifically, the ICTS aims to:

  • Develop a robust workforce that includes research professionals and community stakeholders along with junior and senior investigators to catalyze innovative science. This involves a training program with strong foundational lectures and coursework in scientific design, statistics, regulatory science and other skills, incorporated from successful programs from other CTSA hubs with a focus on flexible formats, including online education. Our program places a strong emphasis on mentoring, with resources specific to translating science to practice through business models and policy change.
  • Create New Methods and Tools to Move Research Participation, Data Collection, and Interventions from the Clinic to the Home. Using approaches that overcome the geographic barriers in a rural state, the ICTS builds on established community practice networks in concert with innovative technologies and their application derived from our center.
  • Promote an Innovative, Integrated Framework for Conducting Clinical and Translational Research. From our tertiary care hospital to our community-based health partners, the ICTS transforms UI Health Care into a model learning health system that effectively engages health care leaders, clinicians, and patients throughout the spectrum of our health system. In support of this goal, the ICTS collaborates with the UI, UI Health Care and our health systems partners to implement strategies that address key requirements for embedding research throughout the institution, state, and nation.


University of Iowa Pappjohn Biomedical Institute

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Pappajohn Biomedical Institute (PBI) is a scientific community seeking to understand the fundamentals of biology and disease and to extend our discoveries into real-life applications that improve human health. PBI members hold academic appointments in departments across the university, and many conduct their research in the hub of the PBI, the Pappajohn Biomedical Discovery Building (PBDB).  The PBDB has an open-floor layout to reduce barriers between scientific and technological specialties and to enable our scientists, engineers, physicians and trainees across disciplines to see, hear, and learn from each other on a daily basis. The PBI aims to translate biomedical discoveries to the clinic or to industry by:

  • Encouraging proof-of-concept and pilot studies to evaluate novel hypotheses
  • Including physicians and clinical scientists, as well as basic scientists as members of the Institute
  • Facilitating human studies through connection with the Institute for Clinical and Translational Science (ICTS)
  • Enlisting a few trusted advisors to facilitate translation to industry and the development of new biotech companies



Carver Family Center for Macular Degeneration

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Carver Family Center for Macular Degeneration is dedicated to providing non-profit genetic testing for rare eye diseases to meet a societal need. Most of the diseases being studied by the Center are so rare that commercial tests would be unlikely to be viable for the long term. As a result, many individuals affected with these diseases and their families would have little access to molecular information. Genes that are available for screening by the Center have previously been extensively studied in the research laboratories of Dr. Edwin Stone and Dr. Val Sheffield at the University of Iowa. By incorporating this research information into test design, the Center is able to offer genetic tests that provide the most clinically relevant information to patients and their families while keeping the tests affordable.


Center for Auditory Regeneration and Deafness

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Iowa Center for Deafness and Auditory Regeneration is designed to create and develop new therapeutic regimens to treat persons with hearing loss. The Center brings together investigators in the Departments of Otolaryngology—Head and Neck Surgery, Anatomy and Cell Biology, Communication Sciences and Disorders, Biology, Physiology and Biophysics, Neurosurgery, Radiology, and the College of Engineering, and is composed of several units including: Auditory Molecular Genetics Laboratories, Auditory Digital Signal Processing Laboratories, Auditory Signal Transduction Laboratories, Auditory Electrophysiology Laboratories, Human Auditory Neurophysiology Laboratory, Micro CT Laboratory, and Cochlear Implant Development Laboratories. The Center enables unique, new, and translational research initiatives by providing the organizational structure to coordinate multidisciplinary research teams, lead the recruitment of needed molecular developmental and signal transduction neuroscientists, and develop focused integrated research questions from the periphery to the central nervous system


Center for Bioinformatics and Computational Biology

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Center for Bioinformatics and Computational Biology (CBCB) aims to catalyze the development of new areas of study and expand research opportunities in informatics areas related to the basic biological sciences and applied medical research. The CBCB was founded in 2002 as a joint enterprise spanning the Colleges of Engineering and Medicine, and involves faculty from 5 Colleges, 7 Afilliated Centers/Institutes/Cores, and more than 19 departments. It serves as a coordinating home for interdisciplinary research, undergraduate, pre- and post-doctoral training, faculty recruitment, and professional development. At the hub of an inherently interdisciplinary field, the goal of the CBCB is to assist in overcoming traditional disciplinary hurdles to collaboration and assist in utilizing state of the art instrumentation and analysis methods needed by 21st century biomedical and basic science research. The CBCB has extensive data storage and processing capabilities, as well as a wealth of installed and maintained software analysis tools to enable research and experiment execution at the leading edge of modern biomedical research.


Center for Gene Therapy

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The ultimate goal of the Center is to foster scientific advancement in gene therapy by providing a focal point for gene therapy research at the University of Iowa. Through centralized core facilities, research meetings, and pilot grants, the Iowa Center for Gene Therapy provides a supportive, interactive, and collaborative environment at the University of Iowa that enables the expansion of new initiatives in gene therapy-based research. The Center supports four research core facilities: the Vector Core, the Animal Models Core, the Cell Morphology and Pathology Core, and the Cells and Tissue Core. These research cores provide equipment, reagents and expertise at a substantial discount to facilitate the research efforts of Center members. The Center hosts a weekly gene therapy seminar, periodic guest seminars, and an annual retreat/symposium. The "work in progress" format of the weekly meetings and retreat provide excellent opportunities for the informal exchange of ideas through which innovative approaches for gene therapy can be developed. In addition, the Center’s Pilot program provides seed money for research on cystic fibrosis in areas relevant to the NIDDK mission. Such research applications should be considered innovative and may potentially be high risk. These applications are funded for one or two years and have a maximum funding limit of $65,000 per year.


Center for Immunology and Immune-Based Diseases

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The mission of the Center for Immunology and Immune-Based Diseases is to achieve an integrated and multidisciplinary approach to the study of immunology in its diverse manifestations. The Center coordinates and facilitates interactions among members of the UI biomedical research community in order to advance education, research, and clinical applications in immune-related diseases. Members include scientists engaged in basic and applied research, education, and clinical studies of immunology and immune-based diseases across the University of Iowa campus community, and thus comprise a diverse group of investigators with a shared interest in immunology in its broadest sense and a collective expertise necessary to advance the understanding of the multifaceted roles of the immune system in biology. Many Center members have conducted corporate-sponsored research projects, as well as collaborative projects that involve multiple institutions. Additionally, Center members use a large number of in vitro and in vivo models of immune responses that may be useful as models for testing pharmaceuticals. The Center holds a monthly Research in Progress seminar in an informal discussion format to allow investigators to receive feedback on grants in the planning stage, novel preliminary findings, or challenging research problems. The Center also holds an annual retreat that enables opportunities for members to establish new collaborations and exchange ideas on research projects.


Craniofacial Anomalies Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

Since its establishment in 1990, the University of Iowa Craniofacial Anomalies Research Center (CARC) has been focused on the identification of genes that contribute to, and the development of treatments for, human cleft lip and palate (CL/P) and palate disorders. The human genetics team based at this Center is harnessing the latest technology to make discoveries in human genetics, which have yielded qualitative and quantitative advances in understanding the etiology of orofacial clefting (OFC). The Center includes clinicians and researchers from multiple departments within the Carver College of Medicine, College of Nursing, College of Dentistry, College of Liberal Arts and Sciences, College of Pharmacy, and College of Public Health. The Center has made many important contributions to the genetic underpinnings of craniofacial anomalies and researchers are currently investigating the causes of clefting by determining how genetics, family history and the environment may influence the risk of having a child with CL/P. In addition, investigators within the Center are also interested in understanding how quality of life, school and well-being are affected by having CL/P. Studies related to acid reflux and healing for patients with clefts are being developed in addition to investigating language and brain function in infants with oral clefts. Center researchers are using adult cells and gene therapy to regenerate alveolar and palatine bone as well soft tissues to deliver better patient care. These new translational approaches fit with the NIH personalized medicine strategies. The Center holds weekly workshops to encourage collaborations with researchers across the nation and mini-symposia on craniofacial and dental research.


Cystic Fibrosis Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The overall goal of the Iowa Cystic Fibrosis Research Center is to understand Cystic Fibrosis (CF) from the level of the gene to the person and to use this knowledge to develop new therapies. The Center adopts a broad-based and multidisciplinary approach and is comprised of basic and clinical scientists approaching key problems in CF. Center investigators have made important discoveries in many areas of CF research, and their findings have helped lead the field, often in exciting new directions. Discoveries by Center investigators have also led to many potential new therapies and are hastening the transfer of basic knowledge to patients. The Center supports several cores including: the In Vitro Models and Cell Culture Core, Morphology Core, Clinical Research Core, Bioinformatics Core, and the Gene Transfer Vector Core. These cores provide specialized expertise, develop new methodologies, attract new scientists, and serve as a catalyst for CF research. In addition, the Center supports fellowships in CF-related research, and interacts closely with the Clinical Center to facilitate translation of basic science to patients and to encourage clinical research.


Francois M. Abboud Cardiovascular Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The François M. Abboud Cardiovascular Research Center (ACRC) was established in 1974 as the first major University of Iowa multidisciplinary, biomedical research initiative. ACRC investigators have made fundamental discoveries that have led to a greater understanding and more skillful management of heart disease and stroke. Key research themes include: arrhythmias and sudden cardiac death; atherosclerosis and vascular biology; cardiomyopathies and muscular dystrophies; cardiovascular genetics and development; cystic fibrosis, pulmonary hypertension, and other lung diseases; diabetes and obesity; hypertension; inflammation; lipids; metabolism; neurological and neurovascular diseases; stroke; transplantation and mechanical assist device therapy; and valvular heart disease. Ongoing studies include basic, translational, clinical, and outcomes research.

The ACRC models a culture of collaboration, team research and mentoring that has been emulated across the UI campus and adopted by most successful academic research institutions. It is is comprised of over 100 researchers and fosters collaborative partnerships among programs, investigators, and cores within and outside the university in areas such as drug, device, and biotech development. Over the years, members have been awarded more than $500 million in federal grant support and trained more than 1000 predoctoral and postdoctoral fellows. The work of ACRC scientists has paved the way for innovative diagnostics, medicines, and treatment strategies while nurturing new generations of dedicated investigators.


Fraternal Order of Eagles Diabetes Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Fraternal Order of Eagles Diabetes Research Center (FOE DRC) at the University of Iowa (UI) is focused on advancing knowledge of the pathophysiology of diabetes and its complications through cutting edge research. The FOE DRC actively recruits and supports the brightest and most creative diabetes researchers in the country, to achieve the goal of being on the forefront of innovative diabetes research and to push the boundaries of what is already known. The FOE DRC plays a pivotal role in institutional efforts to drive translational initiatives that will impact diabetes care and increase public awareness of the importance of the current diabetes epidemic. The FOE DRC provides research scholar awards to tenure track scholars who show outstanding promise in the field of diabetes/obesity research, and a pilot project program to assist investigators hoping to establish or further advance their career in diabetes/obesity research. In addition, the FOE DRC has a T32 training grant that fosters the development of trainees in member laboratories and supports the Metabolic Phenotyping Core and Metabolomics Core Facilities to assist investigators in their research projects.


Helen C. Levitt Center for Viral Pathogenesis and Disease

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Helen C. Levitt Center for Viral Pathogenesis and Disease at the University of Iowa supports interdisciplinary activities directed to understanding the role of viruses in human disease by: supporting educational opportunities for trainees in virology, viral-related immunology, and pathogenesis to strengthen virology research; developing new approaches to viral disease prevention, diagnosis and treatment; and improving professional and public understanding of the nature and impact of viral diseases. The Center is comprised of faculty and trainees from the Departments of Internal Medicine, Microbiology and Immunology, Pediatrics and Pathology. A weekly journal club provides a platform for students to present their own work and to discuss papers containing key research advances for the group. The center supports visiting speakers, and a bi-annual “All Iowa Virology Symposium” joining virologists from the University of Iowa, Iowa State, and other schools, industry, and institutions in the Midwest.  Finally, the Center provides travel funding for graduate students, postdoctoral trainees, and faculty to present their work at national and international virology-related meetings.


Holden Comprehensive Cancer Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The mission of the Holden Comprehensive Cancer Center (HCCC) is to decrease the pain and suffering caused by cancer in Iowa, surrounding communities, and around the world through improved cancer prevention and treatment based on the three interdependent missions of research, clinical service and education. The HCCC has been a recognized cancer center at the University of Iowa since 1980 and is Iowa's only NCI-designated comprehensive cancer center, a designation it has held since 2000. The HCCC coordinates cancer-related patient care, research, and education across many departments and colleges at the University of Iowa. Researchers and treatment specialists meet regularly in one of 15 multidisciplinary oncology groups, 2 of which have received special recognition and funding support from the NCI in the form of a specialized program of research excellence (SPORE). Research programs within the HCCC include: 1) Cancer Genes and Pathways; 2) Experimental Therapeutics; 3) Free Radical Metabolism and Imaging (FRMI); and 4) Cancer Epidemiology and Population Science. The HCCC provides its members with subsidized access to state-of-the-art services and resources available through the core facilities at the University of Iowa. The facilities provide quality products and services that enhance the research efforts of HCCC investigators to foster basic and translational research. In addition, the HCCC operates a tissue repository to preserve and catalog cancerous tissue samples for use by researchers and currently has tumor samples from more than 50,000 patients. The HCCC also operates an Oncology Registry that contains a record of the history and treatment of patients with cancer and precancerous conditions.


Huntington’s Disease Society of America Center of Excellence

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The mission of the Huntington's Disease Society of America Center of Excellence at the University of Iowa is to strengthen the relationship between clinical treatment and research for individuals affected by Huntington disease. The Center take an innovative approach to integrating clinical services, education, outreach, and research opportunities in order to benefit individuals with Huntington disease in a personal way as well as advance scientific efforts in the field of Huntington disease research. The Center supports several Huntington disease studies, including: observational studies and clinical trials. The Center also supports the Huntington’s Disease Clinic at the University of Iowa Hospitals and Clinics, which provides people with Huntington disease and their families with comprehensive medical, psychological, and social services as well as physical therapy, occupational therapy, and genetic counseling.


Iowa Comprehensive Lung Imaging Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Iowa Comprehensive Lung Imaging Center (I-CLIC) represents a group of investigators with a common interest in the use of quantitative imaging techniques to better understand the normal lung and the permutations leading to and defining pathologic states. The Center includes investigators in the departments of Physiology, Medicine, Radiology, Anaesthesiology, Mathematics, Electrical Engineering, Biomedical Engineering, and more. The I-CLIC is home to the Advanced Pulmonary Physiomic Imaging Laboratory (APPIL), which seeks to broaden the understanding of basic physiology and pathophysiology of the lung along with pulmonary disease co-morbidities using quantitative imaging. The APPIL also strives to translate emerging insights from image-based methodologies into tools that are applicable to the broader research community and clinical practice in order to improve the diagnosis, phenotyping, and treatment of lung disease. In addition, APPIL serves as the Radiology Center for a number of NIH-sponsored multi-center studies seeking to utilize imaging as a biomarker for assessing pathology and predicting outcomes. These research efforts are supported by a 2500 square foot CT imaging research facility strategically located between the patient areas of the University of Iowa Hospitals and Clinics, the NIH-supported Clinical Research Unit, and the Animal Care Facilities of the College of Medicine. The imaging facility houses a Dual Energy, Dual Source Multiple Detector Computed Tomography Scanner (Siemens SOMATOM Force) and several MicroCT scanners including an ultra-high resolution MicroCT (Zeiss Xradia 520 Versa) capable of interior tomography of lung specimens with a voxel size down to sub-micron dimensions. In addition, there are other imaging equipment, comprehensive physiologic monitoring, a fully equipped pulmonary function laboratory including spirometry, body plethysmography, and DLCO assessment along with data analysis software, and computer clusters.


National Ferret Resource and Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The major goal of this Center is to provide an NHLBI-focused, centralized resource for genetic modeling in the ferret, with a focus on the distribution of biologic resources to study ferret models of cystic fibrosis and the generation of new ferret models of lung disease. In addition, the Center also forms collaborative partnerships targeting diseases of other organs. The Center has developed CRISPR/Cas9 technologies that make it possible to genetically engineer ferrets by any strategy that has been applied in mice. For example, this technology has enabled the creation of conditional CFTR-knockout (KO) ferrets (i.e., tissue- or cell-type specific protein deletion), G551D- and DF508-CFTR mutant ferrets (models of the most common CFTR mutations in human CF), SERPINA1-KO (AAT-KO) and SERPINA1-PiZZ (AAT-PiZZ) ferrets (which mimic the loss of a protein, or its most common mutation, associated with alpha-1 antitrypsin-deficient lung disease), ROSA-Cre-reporter ferrets (enable lineage tracing), and CreERT2-driver ferrets (enable cell type-specific or temporal control of gene expression). Thus far, 17 distinct genetic ferret models that are directly relevant to the lung have been generated. Collectively, these models will make it possible to address very sophisticated questions based on temporal regulation of gene expression, lineage tracing of stem cells, and the ablation of genes in specific cell types. The Center has also cataloged ferret reagents that are of general use and available through the Center or commercial sources, including: cDNAs, bacterial isolates, primary airway cells from disease models, and recombinant viruses for use in ferrets. In addition, the Center has gathered information on >100 commercially available antibodies that work in ferret tissue samples (by Western blotting, immunostaining, ELISA, and immunoprecipitation), and in some cases has generated new antibodies. The Center continues to catalog antibodies evaluated by other investigators to assist the broader community in finding needed reagents. An initial draft of the ferret genome has been deposited in Ensembl and has enabled the first ferret microarrays on cystic fibrosis ferret lung samples and improved protein identification in ferret proteomics research. The Center is working to provide publically accessible databases and downloadable files with improved annotation of the Ensembl gene and protein IDs (i.e., mass spectrometry Mascot files and excel files).


Neuroendocrine Tumor SPORE center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The University of Iowa and the Holden Comprehensive Cancer Center houses the first and only Specialized Program of Research Excellence (SPORE) in carcinoid and neuroendocrine tumors. This SPORE enables academic, industry, and philanthropic organizations to partner with the National Cancer Institute (NCI) to increase the length and quality of life for children and adults with these rare cancers. The University of Iowa NET SPORE program contains four core services with specific objectives. 

  • The Administration Core maintains excellent communication between all participating NET SPORE investigators and staff and to optimize investigators’ access to additional resources within the University of Iowa and externally. The Administration Core also assures that patient advocates participate in conferences and annual retreats and are included in all key decisions. 
  • The Biospecimens Core obtains high-quality and carefully annotated biospecimens in sufficient quantity to enable our investigators to tackle highly significant scientific questions relating to these perplexing tumors.
  • The Biostatistics and Bioinformatics Core provides statistical design, collaborative analysis, and data management support for each of the Iowa NET SPORE projects, developmental projects, and career enhancement awardees. The Biostatistics and Bioinformatics Core builds a synergistic interaction with investigators through data gatekeeping and with all project groups through data analyses, information sharing, data form development and processing, data collection and entry, data archiving, quality control, and clinical trial data safety monitoring.
  • The Clinical Research Core enables investigators in each SPORE project to bring the fruit of their scientific research to a clinical endpoint that will benefit patients both now and in the future. The Clinical Research Core is the direct translational link between research projects and clinical research emanating from these projects.


Wellstone Muscular Dystrophy Specialized Research Center

Website provided for reference only; hyperlinks/URLs are not typically allowed in NIH grants.

The Wellstone Muscular Dystrophy Specialized Research Center (MDSRC) is engaged in research on various forms of muscular dystrophy and is designed to accelerate progress toward effective treatments for this disease. The Center fosters synergistic collaboration and coordination of research activities, and promotes side-by-side basic, translational, and clinical research. It is one of six NIH funded centers nationwide and serves as a focal point for research collaborations, communication, resource sharing, and training of new muscular dystrophy researchers. The overall goal is to explore therapeutic strategies for the treatment of various muscular dystrophies arising from the abnormal processing of dystroglycan (dystroglycanopathies), with a focus on translating research discoveries on the structure and function of dystroglycan into clinical applications for the diagnosis and treatment of patients with dystroglycan-related muscular dystrophy. The University of Iowa MDSRC is composed of 2 projects and 3 cores. The specific objectives of the MDSRC projects are to (1) identify mechanistic causes and therapeutic strategies for dystroglycan-related muscular dystrophies, and (2) optimize clinical care, and inform and enhance clinical trial design for the dystroglycanopathies. The Center’s 3 cores help to achieve these objectives and include:

  • An Administrative Core that coordinates the activities within and outside the Center and promotes an interactive and collaborative research environment. This Core also educates and engages patients and patient advocates by hosting an annual conference and tours of MDCRC laboratories.  
  • A Muscle Tissue/Cell Culture/Diagnostic Core that serves as a national tissue and cell culture resource for research and provides state-of-the-art diagnostic testing for patients seen at the University of Iowa Hospitals and Clinics and nationwide. This infrastructure provides key support for key projects in the Center and for clinical trials of neuromuscular disease, especially Duchenne muscular dystrophy. 
  • A Research Training Core that supports year-long fellowships for medical students, postdoctoral trainees and undergraduate students.